Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes
10.1007/s10637-009-9305-x
Saved in:
Main Authors: | Chan, D., Yeo, W.-L., Tiemsim Cordero, M., Wong, C.-I., Chuah, B., Soo, R., Tan, S.-H., Lim, S.-E., Goh, B.-C., Lee, S.-C. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/116519 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients
by: Wong, A.L.-A., et al.
Published: (2014) -
Does saturable formation of gemcitabine triphosphate occur in patients?
by: Tham, L.-S., et al.
Published: (2014) -
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
by: Lehnert, M., et al.
Published: (2014) -
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
by: Lehnert, M., et al.
Published: (2016) -
Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014)